Annual Operating Margin
-2063.66%
+2480.08%+54.58%
31 December 2023
Summary:
Celldex Therapeutics annual operating profit margin is currently -2063.66%, with the most recent change of +2480.08% (+54.58%) on 31 December 2023. During the last 3 years, it has fallen by -1395.39% (-208.81%). CLDX annual operating margin is now -14864.90% below its all-time high of -13.79%, reached on 31 December 2010.CLDX Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Margin
-1633.53%
+220.63%+11.90%
01 September 2024
Summary:
Celldex Therapeutics quarterly operating profit margin is currently -1633.53%, with the most recent change of +220.63% (+11.90%) on 01 September 2024. Over the past year, it has increased by +1084.93% (+39.91%). CLDX quarterly operating margin is now -106.83% below its all-time high of 23.90 thousand%, reached on 31 December 1999.CLDX Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Operating Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +54.6% | +39.9% |
3 y3 years | -208.8% | +87.0% |
5 y5 years | -157.6% | +36.1% |
CLDX Operating Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -208.8% | +54.6% | -92.1% | +93.7% |
5 y | 5 years | -208.8% | +54.6% | -502.4% | +93.7% |
alltime | all time | <-9999.0% | +54.6% | -106.8% | +93.7% |
Celldex Therapeutics Operating Margin History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -1633.53%(-11.9%) |
June 2024 | - | -1854.16%(-92.9%) |
Mar 2024 | - | -26.03 K%(+2961.3%) |
Dec 2023 | -2063.66%(-54.6%) | -850.33%(-68.7%) |
Sept 2023 | - | -2718.46%(-78.1%) |
June 2023 | - | -12.39 K%(+269.0%) |
Mar 2023 | - | -3357.91%(+94.2%) |
Dec 2022 | -4543.74%(+205.6%) | -1728.77%(-74.6%) |
Sept 2022 | - | -6804.91%(-60.0%) |
June 2022 | - | -17.01 K%(+24.4%) |
Mar 2022 | - | -13.67 K%(+121.9%) |
Dec 2021 | -1486.73%(+122.5%) | -6163.17%(-51.0%) |
Sept 2021 | - | -12.57 K%(+3217.2%) |
June 2021 | - | -378.79%(-83.9%) |
Mar 2021 | - | -2358.54%(+769.8%) |
Dec 2020 | -668.27%(-56.2%) | -271.15%(-86.8%) |
Sept 2020 | - | -2047.90%(-62.8%) |
June 2020 | - | -5507.20%(+1089.2%) |
Mar 2020 | - | -463.09%(-67.6%) |
Dec 2019 | -1526.03%(+90.5%) | -1428.52%(-44.1%) |
Sept 2019 | - | -2556.41%(+37.7%) |
June 2019 | - | -1856.50%(+80.9%) |
Mar 2019 | - | -1026.11%(+31.4%) |
Dec 2018 | -801.05%(-6.6%) | -780.95%(-50.0%) |
Sept 2018 | - | -1562.06%(+77.6%) |
June 2018 | - | -879.70%(+51.5%) |
Mar 2018 | - | -580.73%(-23.2%) |
Dec 2017 | -857.94%(-56.2%) | -755.96%(+25.9%) |
Sept 2017 | - | -600.43%(-17.7%) |
June 2017 | - | -729.38%(-64.7%) |
Mar 2017 | - | -2067.28%(+11.1%) |
Dec 2016 | -1958.68%(-17.1%) | -1860.76%(+37.7%) |
Sept 2016 | - | -1351.04%(-42.0%) |
June 2016 | - | -2330.17%(-15.0%) |
Mar 2016 | - | -2740.14%(+46.8%) |
Dec 2015 | -2363.89%(-30.8%) | -1867.00%(-40.8%) |
Sept 2015 | - | -3155.07%(+109.8%) |
June 2015 | - | -1503.67%(-76.4%) |
Mar 2015 | - | -6374.69%(+193.8%) |
Dec 2014 | -3414.11%(+72.3%) | -2170.01%(-21.3%) |
Sept 2014 | - | -2755.86%(-42.9%) |
June 2014 | - | -4822.47%(-36.3%) |
Mar 2014 | - | -7569.47%(+112.2%) |
Dec 2013 | -1981.08%(+282.1%) | -3566.77%(+50.2%) |
Sept 2013 | - | -2374.39%(-87.7%) |
June 2013 | - | -19.24 K%(+2568.4%) |
Mar 2013 | - | -720.84%(+58.8%) |
Dec 2012 | -518.45%(+10.7%) | -453.80%(-4.2%) |
Sept 2012 | - | -473.85%(-29.4%) |
June 2012 | - | -671.38%(+22.9%) |
Mar 2012 | - | -546.16%(+7.4%) |
Dec 2011 | -468.42%(+3296.8%) | -508.75%(+4.7%) |
Sept 2011 | - | -485.74%(-4.0%) |
June 2011 | - | -506.20%(+31.9%) |
Mar 2011 | - | -383.86%(-784.1%) |
Dec 2010 | -13.79%(-94.4%) | 56.11%(-115.1%) |
Sept 2010 | - | -370.81%(+17.8%) |
June 2010 | - | -314.67%(+24.2%) |
Mar 2010 | - | -253.35%(-13.0%) |
Dec 2009 | -246.73%(-45.9%) | -291.34%(+64.1%) |
Sept 2009 | - | -177.57%(-45.3%) |
June 2009 | - | -324.88%(+55.7%) |
Mar 2009 | - | -208.63%(-18.4%) |
Dec 2008 | -456.01%(-58.7%) | -255.66%(-29.7%) |
Sept 2008 | - | -363.76%(-31.1%) |
June 2008 | - | -528.12%(-89.5%) |
Mar 2008 | - | -5034.69%(+350.1%) |
Dec 2007 | -1103.35%(-47.2%) | -1118.65%(-28.0%) |
Sept 2007 | - | -1553.04%(+233.2%) |
June 2007 | - | -466.08%(-84.0%) |
Mar 2007 | - | -2918.03%(-3192.1%) |
Dec 2006 | -2090.22% | 94.37%(-105.2%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2006 | - | -1812.66%(+44.9%) |
June 2006 | - | -1251.17%(+1510.5%) |
Mar 2006 | - | -77.69%(-88.5%) |
Dec 2005 | -610.85%(+208.5%) | -674.37%(+22.4%) |
Sept 2005 | - | -551.10%(-28.4%) |
June 2005 | - | -769.62%(+48.8%) |
Mar 2005 | - | -517.19%(+244.5%) |
Dec 2004 | -198.03%(-21.8%) | -150.11%(-79.3%) |
Sept 2004 | - | -723.71%(+61.8%) |
June 2004 | - | -447.18%(+590.3%) |
Mar 2004 | - | -64.78%(-80.8%) |
Dec 2003 | -253.27%(+17.7%) | -336.55%(+212.9%) |
Sept 2003 | - | -107.56%(-63.7%) |
June 2003 | - | -296.32%(-42.0%) |
Mar 2003 | - | -511.12%(+15.4%) |
Dec 2002 | -215.25%(-70.7%) | -442.81%(+4978.1%) |
Sept 2002 | - | -8.72%(-98.9%) |
June 2002 | - | -828.70%(+11.9%) |
Mar 2002 | - | -740.64%(-2.8%) |
Dec 2001 | -734.07%(-63.7%) | -761.87%(-16.0%) |
Sept 2001 | - | -907.20%(+21.7%) |
June 2001 | - | -745.35%(+36.6%) |
Mar 2001 | - | -545.52%(-68.5%) |
Dec 2000 | -2023.17%(+151.3%) | -1731.76%(-38.4%) |
Sept 2000 | - | -2811.31%(+44.8%) |
June 2000 | - | -1941.52%(+2.9%) |
Mar 2000 | - | -1887.65%(-107.9%) |
Dec 1999 | -805.14%(+117.8%) | 23.90 K%(-2756.1%) |
Sept 1999 | - | -900.00%(+211.2%) |
June 1999 | - | -289.20%(-71.1%) |
Mar 1999 | - | -1000.00%(+312.0%) |
Dec 1998 | -369.68%(-42.8%) | -242.73%(-57.8%) |
Sept 1998 | - | -575.00%(+7.8%) |
June 1998 | - | -533.33%(+42.2%) |
Mar 1998 | - | -375.00%(-13.9%) |
Dec 1997 | -646.58%(-39.7%) | -435.58%(-79.3%) |
Sept 1997 | - | -2100.00%(+673.7%) |
June 1997 | - | -271.43%(-86.4%) |
Mar 1997 | - | -2000.00%(+122.2%) |
Dec 1996 | -1072.73%(+263.6%) | -900.00%(-60.9%) |
Sept 1996 | - | -2300.00%(+4.5%) |
June 1996 | - | -2200.00%(+500.0%) |
Mar 1996 | - | -366.67%(+3.1%) |
Dec 1995 | -295.00%(+117.4%) | -355.56%(-13.8%) |
Sept 1995 | - | -412.50%(+90.4%) |
June 1995 | - | -216.67%(-3.7%) |
Mar 1995 | - | -225.00%(+2.3%) |
Dec 1994 | -135.71%(+29.9%) | -220.00%(+32.0%) |
Sept 1994 | - | -166.67%(+41.0%) |
June 1994 | - | -118.18%(+18.2%) |
Mar 1994 | - | -100.00%(-12.0%) |
Dec 1993 | -104.44%(+46.7%) | -113.64%(-17.7%) |
Sept 1993 | - | -138.10%(+79.5%) |
June 1993 | - | -76.92%(-23.1%) |
Mar 1993 | - | -100.00%(+107.1%) |
Dec 1992 | -71.21%(-2.5%) | - |
Oct 1992 | - | -48.28%(-22.8%) |
July 1992 | - | -62.50%(-21.1%) |
Apr 1992 | - | -79.17%(+206.7%) |
Apr 1992 | -73.03%(+69.3%) | - |
Jan 1992 | - | -25.81%(-79.1%) |
Oct 1991 | - | -123.53%(+23.5%) |
July 1991 | - | -100.00%(+92.3%) |
Apr 1991 | -43.14%(+147.5%) | -52.00%(+35.2%) |
Jan 1991 | - | -38.46%(0.0%) |
Oct 1990 | - | -38.46%(-19.9%) |
July 1990 | - | -48.00%(-1732.7%) |
Apr 1990 | -17.43%(-15.0%) | 2.94%(-151.5%) |
Jan 1990 | - | -5.71%(-98.2%) |
Apr 1989 | -20.51%(-52.8%) | -308.70%(-57.4%) |
Apr 1988 | -43.48%(-40.2%) | -725.00%(-59.7%) |
Apr 1987 | -72.73%(-96.2%) | -1800.00% |
Apr 1986 | -1900.00% | - |
FAQ
- What is Celldex Therapeutics annual operating profit margin?
- What is the all time high annual operating margin for Celldex Therapeutics?
- What is Celldex Therapeutics annual operating margin year-on-year change?
- What is Celldex Therapeutics quarterly operating profit margin?
- What is the all time high quarterly operating margin for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly operating margin year-on-year change?
What is Celldex Therapeutics annual operating profit margin?
The current annual operating margin of CLDX is -2063.66%
What is the all time high annual operating margin for Celldex Therapeutics?
Celldex Therapeutics all-time high annual operating profit margin is -13.79%
What is Celldex Therapeutics annual operating margin year-on-year change?
Over the past year, CLDX annual operating profit margin has changed by +2480.08% (+54.58%)
What is Celldex Therapeutics quarterly operating profit margin?
The current quarterly operating margin of CLDX is -1633.53%
What is the all time high quarterly operating margin for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly operating profit margin is 23.90 K%
What is Celldex Therapeutics quarterly operating margin year-on-year change?
Over the past year, CLDX quarterly operating profit margin has changed by +1084.93% (+39.91%)